Effects of cholesterol diets on vascular function and atherogenesis in rabbits

Proceedings of the Society for Experimental Biology and Medicine

Volumn 224, Issue 3, 2000, Pages 166-171

  Sun, Yi Ping ^a,c   Lu, Nancy C ^b   Parmley, William W ^a   Hollenbeck, Clarie B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN JOSE STATE UNIVERSITY   (United States)

^c UCSF Medical Center at Parnassus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL INTAKE; CONCENTRATION RESPONSE; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; RABBIT; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0033946102     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.2000.22416.x     Document Type: Article

References (39)

1. Fruchart JC, Duriez P. High-density lipoproteins and coronary heart disease. Future prospects in gene therapy. Biochimie 80:167-172, 1998.
2. Sun YP, Zhu BQ, Sievers RE, Glantz SA, Parmley WW. Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke. Circulation 89:2260-2265, 1994.
3. Zhu BQ, Sievers RE, Sun YP, Isenberg WM, Parmley WW. Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits. J Cardiovasc Pharmacol 19:246-255, 1992.
4. Zhu BQ, Smith DL, Sievers RE, Isenberg WM, Parmley WW. Inhibition of atherosclerosis by fish oil in cholesterol-fed rabbits. J Am Coll Cardiol 12:1073-1078, 1988.
5. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84:9265-9269, 1987.
6. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526, 1987.
7. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482, 1973.
8. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974.
9. 2. Clin Chem 29:2026-2030, 1983.
10. 2 precipitation and a quantitative lipoprotein electrophoresis assay. Clin Chim Acta 160:1-18, 1986.
11. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta [see comments]. Circulation 83:1057-1062, 1991.
12. Wang BY, Candipan RC, Arjomandi M, Hsiun PT, Tsao PS, Cooke JP. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol 28:1573-1579, 1996.
13. Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, Deedwania PC, Glantz SA, Parmley WW, Chatterjee K. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol 29:800-807, 1997.
14. Hutchison SJ, Glantz SA, Zhu BQ, Sun YP, Chou TM, Chatterjee K, Deedwania PC, Parmley WW, Sudhir K. In utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. J Am Coll Cardiol 32:1463-1467, 1998.
15. Sun YP, Zhu BQ, Sievers RE, Isenberg WM, Parmley WW. Aspirin inhibits platelet activity but does not attenuate experimental atherosclerosis. Am Heart J 125:79-86, 1993.
16. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits [see comments]. J Am Coll Cardiol 21:225-232, 1993.
17. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Moorehead TJ, Parmley WW. Effects of etidronate and lovastatin on the regression of atherosclerosis in cholesterol-fed rabbits. Cardiology 85:370-377, 1994.
18. Zhu B, Sun Y, Sievers RE, Shuman JL, Glantz SA, Chatterjee K, Parmley WW, Wolfe CL. L-arginine decreases infarct size in rats exposed to environmental tobacco smoke. Am Heart J 132:91-100, 1996.
19. Sun YP, Zhu BQ, Sievers RE, Norkus EP, Parmley WW, Deedwania PC. Effects of antioxidant vitamins C and E on atherosclerosis in lipid-fed rabbits. Cardiology 89:189-194, 1998.
20. Breslow JL. Why you should support the American Heart Association! Presented at the 69th scientific sessions of the American Heart Association, November 10, 1996, New Orleans, Louisiana. Circulation 94:3016-3022, 1996.
21. Smith JD, Breslow JL. The emergence of mouse models of atherosclerosis and their relevance to clinical research. J Intern Med 242:99-109, 1997.
22. Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherogenesis. Am J Cardiol 71:9B-14B, 1993.
23. Fontes RC, Almeida L, Paiva I, Tavares P, Cabrita S, Wulfroth P, Matos BM, Teixeira F. Influence of 0.1% or 0.2% cholesterol-enriched diets on the induction of atherosclerosis and aorta reactivity in vitro. J Cardiovasc Pharmacol 31:690-699, 1998.
24. Phivthong-ngam L, Bode-Boger SM, Boger RH, Bohme M, Brandes RP, Mugge A, Frolich JC. Dietary L-arginine normalizes endothelin-induced vascular contractions in cholesterol-fed rabbits. J Cardiovasc Pharmacol 32:300-307, 1998.
25. Laight DW, Matz J, Caesar B, Carrier MJ, Anggard EE. Investigation of endogenous nitric oxide vascular function in the carotid artery of cholesterol-fed rabbits. Br J Pharmacol 117:1471-1474, 1996.
26. Ross R. The pathogenesis of atherosclerosis: An update. N Engl J Med 314:488-500, 1986.
27. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86:228-234, 1990.
28. Simons LA, Sullivan D, Simons J, Celermajer DS. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia. Atherosclerosis 137:197-203, 1998.
29. Radomski MW, Palmer RM, Moncada S. The antiaggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 92:639-646, 1987.
30. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72:403-412, 1993.
31. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 89:2176-2182, 1994.
32. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250:11822-H827, 1986.
33. Osborne JA, Lento PH, Siegfried MR, Stahl GL, Fusman B, Lefer AM. Cardiovascular effects of acute hypercholesterolemia in rabbits: Reversal with lovastatin treatment. J Clin Invest 83:465-473, 1989.
34. Lefer AM, Ma XL. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb 13:771-776, 1993.
35. Minor RJ, Myers PR, Guerra RJ, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 86:2109-2116, 1990.
36. Kato H, Okada R, Enoki M, Oogushi K, Emura S, Takashima T, Ohmori K. The antiatherogenic effect of nifedipine on intramural small coronary arterial lesions in cholesterol-fed rabbits. Angiology 49:49-54, 1998.
37. Candipan RC, Wang BY, Buitrago R, Tsao PS, Cooke JP. Regression or progression: Dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol 16:44-50, 1996.
38. Wilkinson IB, Cockcroft JR. Cholesterol, endothelial function, and cardiovascular disease. Curr Opin Lipidol 9:237-242, 1998.
39. Jeremy RW, McCarron H, Sullivan D. Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit: Response according to treatment duration, anatomic site, and sex. Circulation 94:498-506, 1996.